Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B

Chan Young Jung; Hyung Woo Kim; Sang Hoon Ahn; Seung Up Kim; Beom Seok Kim

doi:10.1016/j.cgh.2021.05.032

Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B

Chan Young Jung, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim

Department of Internal Medicine

Research output: Contribution to journal › Short survey › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	956-958.e2
Journal	Clinical Gastroenterology and Hepatology
Volume	20
Issue number	4
DOIs	https://doi.org/10.1016/j.cgh.2021.05.032
Publication status	Published - 2022 Apr

Bibliographical note

Funding Information:
Funding This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2019R1A2C4070136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Conflicts of interest This author discloses the following: Seung Up Kim has served as an advisory committee member for Gilead Sciences, Bayer, Eisai, and Novo Nordisk; is a speaker for Gilead Sciences, GSK, Bayer, Eisai, AbbVie, EchoSens, MSD, Eisai, Otsuka, and Bristol-Myers Squibb; and has received a research grant from AbbVie and Bristol-Myers Squibb. The other authors disclose no conflicts.

Funding Information:
Funding This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2019R1A2C4070136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cgh.2021.05.032

Cite this

@article{b4571e3a92d14b3b825df1102287cbc8,

title = "Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B",

author = "Jung, {Chan Young} and Kim, {Hyung Woo} and Ahn, {Sang Hoon} and Kim, {Seung Up} and Kim, {Beom Seok}",

note = "Funding Information: Funding This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2019R1A2C4070136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Conflicts of interest This author discloses the following: Seung Up Kim has served as an advisory committee member for Gilead Sciences, Bayer, Eisai, and Novo Nordisk; is a speaker for Gilead Sciences, GSK, Bayer, Eisai, AbbVie, EchoSens, MSD, Eisai, Otsuka, and Bristol-Myers Squibb; and has received a research grant from AbbVie and Bristol-Myers Squibb. The other authors disclose no conflicts. Funding Information: Funding This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2019R1A2C4070136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ",

year = "2022",

month = apr,

doi = "10.1016/j.cgh.2021.05.032",

language = "English",

volume = "20",

pages = "956--958.e2",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B

AU - Jung, Chan Young

AU - Kim, Hyung Woo

AU - Ahn, Sang Hoon

AU - Kim, Seung Up

AU - Kim, Beom Seok

N1 - Funding Information: Funding This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2019R1A2C4070136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Conflicts of interest This author discloses the following: Seung Up Kim has served as an advisory committee member for Gilead Sciences, Bayer, Eisai, and Novo Nordisk; is a speaker for Gilead Sciences, GSK, Bayer, Eisai, AbbVie, EchoSens, MSD, Eisai, Otsuka, and Bristol-Myers Squibb; and has received a research grant from AbbVie and Bristol-Myers Squibb. The other authors disclose no conflicts. Funding Information: Funding This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2019R1A2C4070136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85108621973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108621973&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2021.05.032

DO - 10.1016/j.cgh.2021.05.032

M3 - Short survey

C2 - 34029751

AN - SCOPUS:85108621973

SN - 1542-3565

VL - 20

SP - 956-958.e2

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 4

ER -

Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this